This study demonstrates that a patient education program delivered through a multidisciplinary counselling clinic had high uptake by eligible patients and that patients diagnosed with a BRCA1/2 pathogenic variant who responded to the questionnaire were satisfied with the level of information received and felt well-informed to make decisions about ovarian cancer risk-reduction. The gene discussed is BRCA1; the disease is ovarian cancer.